Mallotus Feretianus Extract Inhibits Ethanol-induced Activation of Hepatic Stellate Cell via PI3K-Akt and cAMP-PKA Pathways (P06-065-19)
Abstract Objectives Chronic and excessive alcohol consumption is a significant cause of liver fibrosis. The development of alcohol induced liver fibrosis may progress to hepatic decompensation and hepatocellular carcinoma. Therefore, liver fibrosis is associated with severe morbidity and mortality. Mallotus furetianus (MF) is a tropical plant in Hainan Island of China. The extract of its leaves is used as a folk medicine. In this study, we examined the effects of MF extract on the development of liver fibrosis in an in vivo ethanol-carbon tetrachloride (CCl4)-induced cirrhosis model and in vitro alcohol-injury model of hepatic stellate cells (HSCs). Methods Male Wistar rats were fed a diet that included 0.012% or 0.04% MF extract or no MF extract. For a period of 3 weeks, the animals were given drinking water containing 5% ethanol and were also treated with CCl4 (0.1 ml/kg of body weight). HSCs were isolated from male Wistar rats and were incubated with ethanol with or without MF extract. Results Plasma ALT and AST activities in rats treated with the ethanol plus CCl4 and MF extract (0.012% or 0.04%) were significantly reduced from the those in rats treated with the ethanol plus CCl4. The protective effect of MF extract was dose dependently. Histological analysis observed lipid and collagen accumulations in the liver of the ethanol plus CCl4-treated rats. On the other hand, MF extract treatment fully protected rats against ethanol plus CCl4-induced liver steatosis and fibrosis. HSCs play a main role in liver fibrosis because they are a primary producer of the extracellular matrix such as type I collagen and α-SMA. MF extract treatment suppressed the ethanol-induced increases in type I and α-SMA expression to near control levels in HSCs. The treatments with MF extract suppressed the increase in the levels of phosphorylated Akt in ethanol-treated HSCs. Furthermore, the treatment of LY194002, an inhibitor of PI3K, suppressed the ethanol-induced increase in the expression of type I collagen in HSCs. On the other hand, the addition of H-89, an inhibitor of PKA, inhibited the suppression of the synthesis of type I collagen in MF extract-treated HSCs. Conclusions MF extract may be a candidate for preventing ethanol-induced liver injury via regulating liver steatosis and fibrosis in PI3K-Akt and cAMP-PKA manners. Funding Sources This study was supported by JSPS KAKENHI Grant Numbers JP24500987, JP15K00832.